Holzkirchen, September 23, 2013 – Sandoz announced today the launch of SurePal™, a new delivery device to optimize the simplicity and security of administering Omnitrope® human growth hormone for patients, their physicians and care givers. SurePal has been CE marked in accordance with European Union (EU) laws on medical devices. The device is now available for […]
Study result signals potential kidney benefit with RLX030;1 future studies will further explore this impact Kidney dysfunction affects approximately 30 percent of US heart failure patients and is associated with worse prognosis of these patients2 Data presented at a late-breaking session at the 17th annual Heart Failure Society of America (HFSA) Scientific Meeting in Orlando, […]
Accuray to Showcase Clinical Utilization and Adoption of its Latest Advanced Product Platforms at ASTRO 2013 World’s Largest Annual Gathering of the Radiation Oncology Community Provides Multiple Opportunities to Learn about the CyberKnife® M6™ Series and the TomoTherapy® H™ Series Systems SUNNYVALE, Calif., September 22, 2013 and ASTRO 2013 (Atlanta)– Accuray Incorporated (Nasdaq: ARAY) announced today […]
New workflow and system architecture designed to improve processing speed, enhance planning productivity ATLANTA, Sept. 21 /PRNewswire/ – Elekta today announced Monaco® 5.0, which consolidates support for all of the most clinically useful delivery techniques in a single treatment planning system, and features refinements to planning speed and precision. “This latest Monaco release brings together […]
ATLANTA, Sept. 21 – Nucletron, an Elekta company, and the world leader in brachytherapy, has launched Esteya®, a new approach for treating patients with skin cancer. Over the last 30 years, more people were diagnosed with skin cancer worldwide than all other cancers combined, making it the most common type of cancer[1]. This represents a […]
TUCSON, Arizona and INGELHEIM, Germany, 19 September 2013 – Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, and Boehringer Ingelheim (BI) announced today that they have entered into an agreement to collaborate on the development of companion diagnostic tests for Boehringer Ingelheim Oncology programmes. As part of the agreement, Ventana will utilize its […]
Robotic-Assisted Surgery Significantly Reduces Complications Compared to Open Surgery SUNNYVALE, Calif., Sept. 16, 2013 (GLOBE NEWSWIRE) — An independent study published online in the journal Urology found that minimally invasive surgery for prostate cancer significantly reduces complications when compared to open surgery. The study found that minimally invasive surgery for prostate cancer, including laparoscopic and robotic-assisted surgery, was associated […]
Mumbai, India, September 12, 2013 – Partnerships with local health authorities support community engagement programs to raise awareness, provide preventive solutions and counter many myths surrounding tuberculosis. Sandoz Global TB, based out of India, has collaborated with the Indian Government’s Ministry of Health to prepare an awareness film on the management of tuberculosis in public health centers […]
SILVER SPRING, Md., Sept. 11, 2013 /PRNewswire/ — United Therapeutics Corporation (NASDAQ: UTHR) announced today that the U.S. Food and Drug Administration (FDA) has acknowledged the resubmission of the new drug application (NDA) for treprostinil diolamine extended release tablets (oral treprostinil) for the treatment of pulmonary arterial hypertension. The FDA classified the resubmission as a […]
MALVERN, Pa., Sept. 9, 2013 /PRNewswire/ — Endo Health Solutions Inc. (Nasdaq: ENDP), a U.S. based specialty healthcare company, announced today that it had appointed Suketu “Suky” Upadhyay as executive vice president and chief financial officer of Endo, effective September 23, 2013. “We are delighted to have Suky join the Endo team at this pivotal […]